Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00285233
What this trial is testing

Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT00001839
What this trial is testing

Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

Who this might be right for
Hematologic DiseasesMyelodysplastic Syndromes
National Institutes of Health Clinical Center (CC) 182
Large-scale testing (Phase 3)UnknownNCT00733733
What this trial is testing

Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

Who this might be right for
Renal Transplant PatientsRecipients of a Kidney From a Non-Heart-Beating Donor
Radboud University Medical Center 180
Testing effectiveness (Phase 2)Study completedNCT00061360
What this trial is testing

Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 77
Testing effectiveness (Phase 2)Study completedNCT00286624
What this trial is testing

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation

Who this might be right for
Type 1 Diabetes MellitusHypoglycemia
University of Minnesota 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862221
What this trial is testing

TReatment for ImmUne Mediated PathopHysiology

Who this might be right for
Acute Liver FailureFulminant Hepatic FailureHepatic Encephalopathy+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 44
Early research (Phase 1)Study completedNCT00014755
What this trial is testing

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00579371
What this trial is testing

Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus

Who this might be right for
Islets of Langerhans TransplantationDiabetes Mellitus, Type 1
University of Nebraska 30
Post-approval studies (Phase 4)Study completedNCT00782821
What this trial is testing

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Cincinnati 40
Testing effectiveness (Phase 2)Ended earlyNCT01517984
What this trial is testing

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

Who this might be right for
Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Testing effectiveness (Phase 2)UnknownNCT00742300
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Charite University, Berlin, Germany
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT00499889
What this trial is testing

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 42
Post-approval studies (Phase 4)UnknownNCT05634915
What this trial is testing

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Leukemia
The First Affiliated Hospital of Soochow University 90
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT05166967
What this trial is testing

Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 204
Testing effectiveness (Phase 2)Study completedNCT03828058
What this trial is testing

Envarsus XL Immunosuppression Following Liver Transplantation

Who this might be right for
Recipients of Liver Transplant
Methodist Healthcare - Memphis 110
Testing effectiveness (Phase 2)Study completedNCT00806767
What this trial is testing

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Institut Paoli-Calmettes 82
Large-scale testing (Phase 3)Study completedNCT01295710
What this trial is testing

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
GVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more
Neovii Biotech 260
Next Page